Shanghai Pharmaceuticals Holding Co Ltd Class H (SHPMF)
OTHER OTC:SHPMF
Total Valuation
Shanghai Pharmaceuticals Holding Co has a market cap or net worth of $8.41B. The enterprise value is $80.95B.
Market Cap$8.41B
Enterprise Value$80.95B
Share Statistics
Shanghai Pharmaceuticals Holding Co has 919,072,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding919,072,700
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
Shanghai Pharmaceuticals Holding Co’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 4.97%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)4.97%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee5.74M
Profits Per Employee141.16K
Employee Count49,402
Asset Turnover1.22
Inventory Turnover5.58
Valuation Ratios
The current PE Ratio of Shanghai Pharmaceuticals Holding Co is ―. Shanghai Pharmaceuticals Holding Co’s PEG ratio is 0.00.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.00
Price to FCF0.00
Price to Operating Cash Flow10.05
PEG Ratio0.00
Income Statement
In the last 12 months, Shanghai Pharmaceuticals Holding Co had revenue of 283.58B and earned 5.72B in profits. Earnings per share was 1.54.
Revenue283.58B
Gross Profit30.42B
Operating Income9.94B
Pretax Income9.82B
Net Income5.72B
EBITDA14.37B
Earnings Per Share (EPS)1.54
Cash Flow
In the last 12 months, operating cash flow was 6.37B and capital expenditures -2.34B, giving a free cash flow of 4.03B billion.
Operating Cash Flow6.37B
Free Cash Flow4.03B
Free Cash Flow per Share4.38
Dividends & Yields
Shanghai Pharmaceuticals Holding Co pays an annual dividend of $0.04, resulting in a dividend yield of 3.35%
Dividend Per Share$0.04
Dividend Yield3.35%
Payout Ratio18.75%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.25
52-Week Price Change6.27%
50-Day Moving Average1.49
200-Day Moving Average1.52
Relative Strength Index (RSI)60.08
Average Volume (3m)0.00
Important Dates
Shanghai Pharmaceuticals Holding Co upcoming earnings date is Apr 30, 2026, TBA (Confirmed).
Last Earnings DateMar 30, 2026
Next Earnings DateApr 30, 2026
Ex-Dividend Date―
Financial Position
Shanghai Pharmaceuticals Holding Co as a current ratio of 1.33, with Debt / Equity ratio of 65.19%
Current Ratio1.33
Quick Ratio1.00
Debt to Market Cap0.00
Net Debt to EBITDA1.17
Interest Coverage Ratio5.90
Taxes
In the past 12 months, Shanghai Pharmaceuticals Holding Co has paid 2.85B in taxes.
Income Tax2.85B
Effective Tax Rate0.29
Enterprise Valuation
Shanghai Pharmaceuticals Holding Co EV to EBITDA ratio is 1.17, with an EV/FCF ratio of 4.38.
EV to Sales0.06
EV to EBITDA1.17
EV to Free Cash Flow4.38
EV to Operating Cash Flow2.72
Balance Sheet
Shanghai Pharmaceuticals Holding Co has $43.08B in cash and marketable securities with $49.48B in debt, giving a net cash position of -$6.39B billion.
Cash & Marketable Securities$43.08B
Total Debt$49.48B
Net Cash-$6.39B
Net Cash Per Share-$6.96
Tangible Book Value Per Share$0.00
Margins
Gross margin is 10.73%, with operating margin of 3.51%, and net profit margin of 2.02%.
Gross Margin10.73%
Operating Margin3.51%
Pretax Margin3.46%
Net Profit Margin2.02%
EBITDA Margin5.07%
EBIT Margin4.06%
Analyst Forecast
The average price target for Shanghai Pharmaceuticals Holding Co is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―